$2.15
+0.25 (+13.16%)
Open$1.90
Previous Close$1.90
Day High$2.22
Day Low$1.88
52W High$67.00
52W Low$1.43
Volume—
Avg Volume228.7K
Market Cap153.58M
P/E Ratio—
EPS$-0.06
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 66.78M | 62.47M | 71.10M |
| Net Income | 5.53M | 4.95M | 5.20M |
| Profit Margin | 8.3% | 7.9% | 7.3% |
| EBITDA | 7.58M | 8.61M | 8.78M |
| Free Cash Flow | 4.38M | 4.03M | 6.15M |
| Rev Growth | +15.6% | -3.5% | +12.7% |
| Debt/Equity | 0.23 | 0.21 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |